Constitutively-active ALK6QD receptor expression decreases the proliferation of human prostate cancer cells as well as their ability to form tumours in nude mice[36], whereas blocking BMP signalling by expression of dominant-negative BMPR2 enhances prostate cancer tumorigenicity[37]. The gene discussed is BMPR2; the disease is neoplasm.